ORCL
Oracle Corporation
ORCL has lower modeled downside risk, despite its lower overall score.
SMCI
Super Micro Computer, Inc.
SMCI has the edge over ORCL overall, supported by stronger modeled upside and stronger valuation.
ORCL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Weak | |
| Strong |
ORCL's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
SMCI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Weak | |
| Strong |
SMCI's revenue, profitability and balance sheet are currently strong, but its cash flow is weak.
ORCL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 15x | $127 | — |
| Cheap | 19x | $119 | -6.8% |
| Current | 20x | $127 | — |
| Fair | 30x | $189 | +49% |
| Expensive | 39x | $247 | +94% |
Historical ranges are pointers, not guarantees.
ORCL's PE is in its cheap range at 20x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.
SMCI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.3x | $26.99 | — |
| Current | 5.7x | $26.99 | — |
| Cheap | 13x | $61.50 | +128% |
| Fair | 19x | $88.86 | +229% |
| Expensive | 26x | $125 | +363% |
Historical ranges are pointers, not guarantees.
SMCI has the edge over ORCL in the historical PE scenario, which offers more potential upside but is not a forecast.
ORCL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for ORCL, but weaker profitability.
SMCI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Moderate | |
| Low |
SMCI has the edge over ORCL on the outlook, with more favorable profitability expectations.
ORCL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.53 | +34% |
| Q3 2026 | $6.38 | +48% |
| Q2 2026 | $5.83 | +34% |
| Q1 2026 | $5.57 | +31% |
| Q4 2025 | $5.32 | +30% |
| Q3 2025 | $4.32 | +11% |
| Q2 2025 | $4.34 | +17% |
| Q1 2025 | $4.26 | +12% |
| Q4 2024 | $4.09 | +13% |
ORCL has the edge over SMCI on earnings, with more consistent year-over-year improvement.
SMCI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.22 | +31% |
| Q3 2026 | $4.75 | +274% |
| Q2 2026 | $3.26 | +94% |
| Q1 2026 | $1.91 | +4.4% |
| Q4 2025 | $1.36 | -41% |
| Q3 2025 | $1.27 | -45% |
| Q2 2025 | $1.68 | -13% |
| Q1 2025 | $1.83 | +2.8% |
| Q4 2024 | $2.32 | +81% |
SMCI's earnings per share have jumped to their highest in seven years: $4.75 over the past year, up from $1.27 the year before.
ORCL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19.3B | +30% |
| Q2 2026 | $19.2B | +21% |
| Q1 2026 | $17.2B | +22% |
| Q4 2025 | $16.1B | +14% |
| Q3 2025 | $14.9B | +12% |
| Q2 2025 | $15.9B | +11% |
| Q1 2025 | $14.1B | +6.4% |
| Q4 2024 | $14.1B | +8.6% |
ORCL's revenue has grown year over year for 13 quarters in a row: $19.3B last quarter, up 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 35% | +6.1 points |
| Q2 2026 | 32% | -0.2 points |
| Q1 2026 | 32% | +0.9 points |
| Q4 2025 | 29% | -0.6 points |
| Q3 2025 | 29% | -1.3 points |
| Q2 2025 | 32% | -0.7 points |
| Q1 2025 | 31% | +2.6 points |
| Q4 2024 | 30% | +2 points |
ORCL has the edge over SMCI on profitability, with a higher operating margin.
SMCI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19.9B | +298% |
| Q2 2026 | $11.1B | +93% |
| Q1 2026 | $10.2B | +123% |
| Q4 2025 | $12.7B | +123% |
| Q3 2025 | $5B | -15% |
| Q2 2025 | $5.8B | +7.5% |
| Q1 2025 | $4.6B | +19% |
| Q4 2024 | $5.7B | +55% |
SMCI's revenue has grown year over year for four quarters in a row: $19.9B last quarter, up 298% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | +6.7 points |
| Q2 2026 | 13% | +9.4 points |
| Q1 2026 | 6.1% | +2.9 points |
| Q4 2025 | 3.7% | -2.8 points |
| Q3 2025 | 3.6% | -5 points |
| Q2 2025 | 4% | -1.4 points |
| Q1 2025 | 3.2% | -6.6 points |
| Q4 2024 | 6.5% | -3.7 points |
SMCI's operating margin was 10% last quarter, up 6.7 points from the same quarter a year ago.
ORCL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.4B | -$5B |
| Q2 2026 | -$1.9B | +$1.1B |
| Q1 2026 | -$11.5B | -16275% |
| Q4 2025 | -$10B | -$7.3B |
| Q3 2025 | -$362M | -107% |
| Q2 2025 | -$2.9B | -189% |
| Q1 2025 | $71M | -98% |
| Q4 2024 | -$2.7B | -$1.7B |
ORCL has burned cash in seven of the last eight quarters: −$28.7B over the past year, against −$5.9B the year before.
SMCI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$475.6M | +$474.2M |
| Q2 2026 | $718.7M | -15% |
| Q1 2026 | -$6.7B | -1227% |
| Q4 2025 | -$45.1M | +$222.2M |
| Q3 2025 | -$949.8M | -360% |
| Q2 2025 | $840.9M | +$1.5B |
| Q1 2025 | $594.1M | +$2.2B |
| Q4 2024 | -$267.3M | +$342.5M |
SMCI has the edge over ORCL on cash flow, with more consistent year-over-year improvement.
ORCL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3% | +86M shares |
| 1 year | +3.1% | +91M shares |
| 3 years | +6.3% | +177M shares |
| 5 years | +4.9% | +139M shares |
| Available history | -9.9% | -331M shares |
ORCL has the edge over SMCI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $95M |
| Q2 2025 | $150M |
| Q1 2025 | $150M |
| Q4 2024 | $150M |
| Q3 2024 | $150M |
SMCI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.5% | +52M shares |
| 1 year | +13% | +86.1M shares |
| 3 years | +31% | +178M shares |
| 5 years | +42% | +220M shares |
| Available history | +44% | +229M shares |
SMCI has 749M diluted shares, up 13% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2024 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | $12M |
| Q1 2021 | $43.1M |
| Q4 2020 | $46.4M |
ORCL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.9x | Net Cash |
| Q2 2026 | 3.5x | Elevated |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | 3.7x | Elevated |
| Q1 2025 | 0.2x | Very low |
| Q4 2024 | 0.2x | Very low |
ORCL has the edge over SMCI on leverage, with a lower net debt burden relative to earnings.
SMCI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 0.2x | Very low |
SMCI has more cash than debt.
ORCL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.9 | Neutral |
| Stochastic | 23.0 | Neutral |
ORCL's weekly RSI is 42 (neutral) and its Stochastic is 23 (neutral).
SMCI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.8 | Neutral |
| Stochastic | 19.1 | Oversold |
SMCI's weekly RSI is 41 (neutral) and its Stochastic is 19 (oversold).
ORCL PE vs Technology Sector
| Metric | ORCL | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 28x | 28% below |
| PE % | 28 | 35 | 7 pts below |
ORCL is trading at 20x earnings, a 28% discount to the Technology sector's median of 28x.
SMCI PE vs Technology Sector
| Metric | SMCI | Sector median | Relative |
|---|---|---|---|
| PE | 5.7x | 28x | 80% below |
| PE % | 0 | 35 | 35 pts below |
SMCI has the edge over ORCL on valuation relative to its sector.
ORCL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $131.1 | 3.1% below |
| 20 week MA | $137.6 | 7.7% below |
| 50 week MA | $160.3 | 21% below |
| 100 week MA | $181.4 | 30% below |
| 200 week MA | $151.9 | 16% below |
ORCL is in a downtrend: it's below all five of its weekly moving averages, and 16% below its 200-week average.
SMCI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $35.3 | 23% below |
| 20 week MA | $34.2 | 21% below |
| 50 week MA | $32.3 | 17% below |
| 100 week MA | $36.9 | 27% below |
| 200 week MA | $39.8 | 32% below |
SMCI is in a downtrend: it's below all five of its weekly moving averages, and 32% below its 200-week average.
ORCL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $53.5 | $65.0 | +22% |
| 2021 | $65.0 | $89.7 | +38% |
| 2022 | $89.7 | $80.9 | -9.9% |
| 2023 | $80.9 | $105.4 | +30% |
| 2024 | $105.4 | $169.0 | +60% |
| 2025 | $169.0 | $198.0 | +17% |
| 2026 YTD | $198.0 | $127.1 | -36% |
ORCL is down 36% so far in 2026, after finishing higher in five of the previous six years.
SMCI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.41 | $3.05 | +27% |
| 2021 | $3.05 | $4.27 | +40% |
| 2022 | $4.27 | $8.22 | +93% |
| 2023 | $8.22 | $28.4 | +246% |
| 2024 | $28.4 | $32.0 | +12% |
| 2025 | $32.0 | $30.6 | -4.2% |
| 2026 YTD | $30.6 | $27.0 | -12% |
SMCI has the edge over ORCL on returns for 2026, with the stronger performance.